Clinical trials
Active, not recruiting Phase 2 trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,301 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 3 |
| 2006 | 9 |
| 2007 | 7 |
| 2008 | 15 |
| 2009 | 16 |
| 2010 | 16 |
| 2011 | 20 |
| 2012 | 29 |
| 2013 | 37 |
| 2014 | 48 |
| 2015 | 76 |
| 2016 | 114 |
| 2017 | 155 |
| 2018 | 205 |
| 2019 | 285 |
| 2020 | 313 |
| 2021 | 382 |
| 2022 | 354 |
| 2023 | 402 |
| 2024 | 417 |
| 2025 | 307 |
| 2026 | 77 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3,301 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 205 |
| M.D. Anderson Cancer Center | 175 |
| Memorial Sloan Kettering Cancer Center | 126 |
| Dana-Farber Cancer Institute | 42 |
| AstraZeneca | 40 |
| City of Hope Medical Center | 40 |
| Sun Yat-sen University | 37 |
| Novartis Pharmaceuticals | 35 |
| Massachusetts General Hospital | 33 |
| Mayo Clinic | 30 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 189 |
| Carcinoma, Non-Small-Cell Lung | 146 |
| Multiple Myeloma | 119 |
| Prostatic Neoplasms | 113 |
| Neoplasms | 79 |
| Colorectal Neoplasms | 72 |
| Squamous Cell Carcinoma of Head and Neck | 71 |
| Leukemia, Myeloid, Acute | 70 |
| Melanoma | 70 |
| Lung Neoplasms | 65 |
Trials
Showing 1 to 25 of 3,301. Each trial links to its page on Pharma Observatory.
3,201 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.